Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-12-022023
Filing Date
2012-03-28
Accepted
2012-03-28 16:30:48
Documents
1
Period of Report
2012-03-20

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3787
  Complete submission text file 0001104659-12-022023.txt   5389
Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 12720942

Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations